Inhaled nitric oxide improves hemodynamics in patients with acute pulmonary hypertension after high-risk cardiac surgery

Abstract

Severe pulmonary hypertension and right-sided circulatory failure (RSCF) represent an increasing cause of morbidity and mortality in patients undergoing high-risk cardiac surgery. Increased pulmonary vascular resistance in the setting of cardiopulmonary bypass (CPB) may further lead to decreased blood flow across the pulmonary vascular bed; thereby decreasing left ventricular filling and cardiac output. Current management techniques for RSCF include both nonspecific vasodilator and inotropic agents (often limited by systemic hypotension) and the placement of right ventricular assist devices (associated with increased perioperative morbidity). Inhaled nitric oxide (NOi) represents a novel, specific pulmonary vasodilator that has been proven efficacious in these clinical settings.

We evaluated 34 patients in 38 operations who underwent cardiac surgery at Columbia Presbyterian Medical Center, and who received NOi (20 ppm) through a modified ventilatory circuit for hemodynamically significant elevations in pulmonary vascular resistance. Nine patients underwent cardiac transplantation, three patients bilateral lung transplantation, 16 patients left ventricular assist device placement and 10 patients routine cardiac surgery.

Patients receiving NOi exhibited substantial reductions in mean pulmonary artery pressure (mPAP) (34.6 ± 2.0 to 26.0 ± 1.7 mmHg, p < 0.0001), with improvements in systemic hemodynamics, mean arterial pressure (68 ± 3.1 to 75.9 ± 2.0 mmHg, p = 0.006). In five cases, patients could not be weaned from CPB until NOi was administered. Patients were maintained on NOi from 6 to 240 h postoperatively (median duration 36 h).

Inhaled NO induces substantial reductions in mPAP and increases in both cardiac index and systemic blood pressure in patients displaying elevated pulmonary hemodynamics after high-risk cardiac surgery. NO is, therefore, a useful adjunct in these patients in whom acute pulmonary hypertension threatens right ventricular function and hemodynamic stability.

Get full access to this article

View all access options for this article.

References

Frazier OH , Rose EA , Macmanus Q et al. Multicenter clinical evaluation of the Heartmate 1000 IP left ventricular assist device . Ann Thorac Surg 1992; 53: 1080-1090 .

Kirklin JK , Naftel DC , McGiffin DC , McVay, Blackstone EH , Karp RB. Analysis of morbid events and risk factors for death after cardiac transplantation . J Am Coll Cardiol 1988; 11: 917-924 .

Smith WJ , Murphy MP , Appleyard RF et al. Prevention of complement-induced pulmonary hypertension and improvement of right ventricular function by selective thromboxane receptor antagonism . J Thorac Cardiovasc Surg 1994; 107: 800-806 .

Elberery JR , Owen CH , Savitt MA et al. Effects of the left ventricular assist device on right ventricular function . J Thorac Cardiovasc Surg 1990; 99: 809-816 .

Kirklin JK , Westaby S , Blackson EH , Chenoweth DE , Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass . J Thorac Cardiovasc Surg 1983; 86: 845-857 .

Komai H. Yomamoto F , Tanaka K et al. Increased lung injury in pulmonary hypertensive patients during open heart operations . Ann Thorac Surg 1993; 55: 1147-1152 .

Wessel DL , Adatia I , Giglia TM , Thompson JE , Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass . Circulation 1993; 88: 2128-2138 .

Kirklin JK. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass [editorial] . Ann Thorac Surg 1991; 51: 529-531 .

Packer M , Greenberg B , Massie B , Dash H. Deleterious effects of hydralazine in patients with pulmonary hypertension . N Engl J Med 1982; 306: 1326-1331 .

10.

Kadowitz PJ , Hyman AL. Hydralazine and the treatment of primary pulmonary hypertension . N Engl J Med 1982; 306: 1357-1359 .

11.

Fullerton DA , McIntyre RC. Inhaled nitric oxide: therapeutic applications in cardiothoracic surgery . Ann Thorac Surg 1996; 61: 1856-1864 .

12.

Rossaint R , Falke KJ , Lopez F , Slama K , Pison U , Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome . N Engl J Med 1993; 328: 399-405 .

13.

McIntyre RC Jr , Moore FA , Moore EE , Piedalue F , Haenel JS , Fullerton DA. Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome . J Trauma 1995; 39: 418-425 .

14.

Pepke-Zaba J , Higenbottam TW , Dinh Xuan AT , Stone D , Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension . Lancet 1991; 338: 1173-1174 .

15.

Roberts JD Jr , Lang P , Bigatello LM , Vlahakes GJ , Zapol WM , Inhaled nitric oxide in congenital heart disease . Circulation 1993; 87: 447-453 .

16.

Kieler-Jensen N , Lundin S , Ricksten SE. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside . J Heart Lung Transplant 1995; 14: 436-443 .

17.

Argenziano M , Choudhri AF , Moazami N et al. A randomized, placebo-controlled trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension . Ann Thorac Surg 1997; 65: 340-345 .

18.

Griepp R , Stinson E , Dong E , Clark D , Shumway N. Determinants of operative risk in human heart transplantation . Am J Surg 1971; 122: 192-197 .

19.

Kirklin J , Naftel D , Blackstone E , White-Williams C , Bourge R. Pulmonary vascular resistance and the risk of heart transplantation . J Heart Transplant 1988; 7: 331-336 .

20.

Addonizio L , Gersony W , Robbins R. Elevated pulmonary vascular resistance and cardiac transplantation . Circulation 1987; 76 (suppl V): V52-V55 .

21.

Girard C , Lehot J-J , Pannetier J-C , Filley S , Ffrench P , Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension . Anesthesiology 1992; 77: 880-883 .

22.

Fullerton DA , Jaggers J , Wollmering MM , Piedalue FP , Grover FL , McIntyre RC. Variable response to inhaled nitric oxide after cardiac surgery . Ann Thorac Surg 1997; 63: 1251-1256 .